-
1
المؤلفون: Geng Zhang, Jie Mao, Shude Cui, Zhaorui Liu, Bin Zhou, Siyuan Wang, Ying-Ying Xu, Rui Ling, Zefei Jiang, Zhuo Zhang, Tao Wang, Zhigang Yu, Jianguo Zhang, Qianxin Liu, Baoliang Guo, Ke Luo, Shu Wang, Lixiang Yu, Dahua Mao, Yimin Cui, Bing Han, Chuan Wang, Chao Ma, Ting Wang, Zhimin Fan, Weiwei Tong, Yin-Hua Liu, Zhenzhen Liu, Fangmeng Fu, Qian Xiang, Feng Jin, Ling Xu, Xuening Duan, Y Liu
المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Multivariate analysis, lcsh:RC254-282, Systemic therapy, CPS + EG, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Trastuzumab, HER2, Internal medicine, medicine, Neo-Bioscore, Original Research, Proportional hazards model, business.industry, breast cancer prognosis, Area under the curve, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Clinical trial, 030104 developmental biology, preoperative systemic therapy, 030220 oncology & carcinogenesis, business, Cohort study, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b86f33447b61f18f6da16bcf0419d50f
https://doi.org/10.3389/fonc.2021.606477